K. Stringaris

发表

The importance of natural killer cell killer immunoglobulin-like receptor-mismatch in transplant outcomes

A. Barrett, K. Stringaris, 2017, Current opinion in hematology.

Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia

K. Rezvani, D. Marin, E. Shpall, 2014, Haematologica.

KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib

D. Marin, L. Foroni, D. Milojković, 2012, Leukemia.

Donor KIR Genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid leukemia but not other hematologic malignancies.

Marcela R. Uribe, S. Adams, A. Barrett, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

through off-target inhibition of kinases important for cell signaling Tyrosine kinase inhibitors impair B-cell immune responses in CML

D. Marin, E. Shpall, D. Milojković, 2013 .

A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML.

R. Başar, K. Rezvani, D. Marin, 2017, Blood.

Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host

K. Rezvani, D. Marin, J. Goldman, 2011, Haematologica.

Humoral and cellular immunity to primary H1N1 infection in patients with hematologic malignancies following stem cell transplantation.

S. Brett, K. Rezvani, D. Marin, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Opportunities and limitations of NK cells as adoptive therapy for malignant disease

K. Rezvani, J. Barrett, James O. J. Davies, 2014 .

Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD.

K. Rezvani, S. Parmar, E. Shpall, 2014, Blood.

Intrabone transplantation of CD34+ cells with optimized delivery does not enhance engraftment in a rhesus macaque model.

R. F. Hoyt, P. Choyke, W. Telford, 2020, Blood advances.

Perforation of the alimentary tract: evaluation with computed tomography

A. Roussakis, K. Stringaris, J. Andreou, 2000, Abdominal Imaging.

Perforation of the alimentary tract: evaluation with computed tomography

A. Roussakis, K. Stringaris, J. Andreou, 2000 .

Editorial: Should child psychiatry be more like paediatric oncology?

A. Stringaris, K. Stringaris, 2018, Journal of child psychology and psychiatry, and allied disciplines.

In Vivo Tracking of Adoptively Transferred Natural Killer Cells in Rhesus Macaques Using 89Zirconium-Oxine Cell Labeling and PET Imaging

P. Choyke, R. Childs, C. Dunbar, 2020, Clinical Cancer Research.

Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

A. Barrett, M. Bevans, S. Mitchell, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML.

M. Mohty, C. Hourigan, U. Borate, 2021, Blood advances.

Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling.

K. Rezvani, D. Marin, E. Shpall, 2013, Blood.

Sigmoid carcinoma incidentally discovered after perforation caused by an ingested chicken bone.

A. Roussakis, K. Stringaris, E. Vardaki, 2001, AJR. American journal of roentgenology.

Assessment of intraocular foreign bodies by helical-CT multiplanar imaging

A. Michaelides, K. Stringaris, A. Papadopoulos, 2001, European Radiology.

Dasatinib may overcome the negative prognostic impact of KIR2DS1 in newly diagnosed patients with chronic myeloid leukemia.

K. Rezvani, R. Clark, D. Marin, 2012, Blood.

Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease.

K. Rezvani, A. Barrett, James O. J. Davies, 2014, Cytotherapy.